GuyL.ReedIIIMD
Cardiology • Memphis, TNAdult Congenital Heart Disease
Lemuel Diggs Alumni Professor, Medicine, University of Tennessee Health
Are you Dr. Reed?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1407 Union Ave
Suite 200
Memphis, TN 38104Phone+1 901-866-8813Fax+1 901-302-2120
Summary
- Dr. Guy Reed III, MD is a cardiologist in Memphis, Tennessee. He is currently licensed to practice medicine in Tennessee, Arizona, and Georgia. He is a Lemuel Diggs Alumni Professor at University of Tennessee Health.
Education & Training
Stanford University School of MedicineClass of 1981
Certifications & Licensure
AZ State Medical License 2020 - 2026
TN State Medical License 2008 - 2022
GA State Medical License 2004 - 2017
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- 1 citationsTargeting Fibrinolytic Inhibition for Venous Thromboembolism Treatment: Overview of an Emerging Therapeutic Approach.Satish Singh, Pardeep Kumar, Yogendra S Padwad, Farouc A Jaffer, Guy L Reed
Circulation. 2024-09-10 - 6 citationsFalling corin and ANP activity levels accelerate development of heart failure and cardiac fibrosis.Inna P Gladysheva, Ryan D Sullivan, Guy L Reed
Frontiers in Cardiovascular Medicine. 2023-01-01 - 1 citationsNeprilysin and Corin in HF: Does Combining 2 Biomarkers Double Our Insights?Inna P. Gladysheva, Ryan D. Sullivan, Guy L. Reed
JACC. Heart Failure. 2021-05-01
Press Mentions
Three Medical Students Receive the 2021 MICA ScholarshipOctober 14th, 2021- Faculty Recognized for Outstanding TeachingJune 9th, 2021
- College Hosts 25th Annual Academic Excellence DayMay 26th, 2021
- Join now to see all
Grant Support
- Strategy for Improving Stroke Treatment Response (SISTER) TrialUNIVERSITY OF CINCINNATI2023–2028
- Strategy for Improving Stroke Treatment Response (SISTER) TrialUNIVERSITY OF CINCINNATI2023–2028
- Strategy for Improving Stroke Treatment Response (SISTER) TrialUNIVERSITY OF CINCINNATI2023–2028
- Novel α2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi (NAIL-IT) TrialTRANSLATIONAL SCIENCES, INC.2021–2025
- Preventing Neurovascular Matrix Degradation and Hemorrhage in Acute Ischemic StrokeTRANSLATIONAL SCIENCES, INC.2019–2025
